Loading...
Keywords
Last Name
Institution

Search Results (23)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Cytochrome P-450 CYP2C9Concept Why?
Cytochrome P-450 CYP2C9 InducersConcept Why?
Cytochrome P-450 CYP2C9 InhibitorsConcept Why?
CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements.Academic Article Why?
Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations.Academic Article Why?
Efficiency of CYP2C9 genetic test representation for automated pharmacogenetic decision support.Academic Article Why?
Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype.Academic Article Why?
Effects of fluvastatin and cigarette smoking on CYP2C9 activity measured using the probe S-warfarin.Academic Article Why?
VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.Academic Article Why?
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.Academic Article Why?
Gaedigk, AndreaPerson Why?
Limited sampling strategy of S-warfarin concentrations, but not warfarin S/R ratios, accurately predicts S-warfarin AUC during baseline and inhibition in CYP2C9 extensive metabolizers.Academic Article Why?
Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe.Academic Article Why?
Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes.Academic Article Why?
Leeder, J. StevenPerson Why?
Per Page    Page  of 2last Nextnext
Prev
Search Criteria
  • CYP2C9
Filter by Type